Back

Catheter ablation as first versus second-line therapy for atrial fibrillation: a frequentist and bayesian meta-analysis with reconstructed time-to-event and trial sequential analysis

14 April 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation catheter ablation: procedural outcomes Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Andrei Anghel

University of Medicine and Pharmacy Carol Davila, Bucharest (Romania)

5 More presentations in this session

Presentation thumbnail
Pulmonary vein isolation with or without empirical cavotricuspid isthmus ablation
Doctor R. Hoffmann (Hasselt, BE)
Abstract Slides Video
Presentation thumbnail
Pulsed-field ablation does not lead to left atrial function impairment following pulmonary vein isolation compared with thermal ablation
Doctor J. Obergassel (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
The effect of weight loss on atrial fibrillation freedom compared to catheter ablation: a sub-analysis of the PRAGUE-25 trial
Doctor D. Herman (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Comparison of spatiotemporal dispersion electrogram ablation and low voltage zone ablation in patients with persistent atrial fibrillation
Doctor Y. Kaneko (Hamamatsu, JP)
Abstract Slides Video
Presentation thumbnail
Impact of atrial fibrillation catheter ablation on primary prevention ICD eligibility in heart failure with reduced ejection fraction: a systematic review and meta-analysis
Doctor F. Landra (Cuneo, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation catheter ablation: procedural outcomes

The Event

Event poster

EHRA 2026

14 April 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of catheter ablation for paroxysmal atrial fibrillation as first-line therapy vs. after drug failure -analysis from Japan Nationwide Ablation (J-AB) Registry-
thumbnail
Congress Presentation
Strategic timing- early and delayed catheter ablation in atrial fibrillation
thumbnail
Congress Presentation
A multicenter, prospective, randomized trial of treatment for early persAF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources